Novartis

CVMP opinions on veterinary medicinal products 12-11-2012 — /europawire.eu/ — The Committee adopted by consensusa positive opinion for an initial marketing authorisation for Kexxtone continuous-release intraruminal device for cattle (monensin) from Eli Lilly and Company Limited. The product is intended for the reduction of … Read the full press release →

Basel, November 12-11-2012 — /europawire.eu/ — Novartis announced today that Marjorie Yang has decided not to seek re-election to the Novartis Board of Directors at the Novartis Annual General Meeting in 2013. Ms. Yang joined the Novartis Board in 2007 and her … Read the full press release →

Pharmaceuticals Division growth over the next 5 years expected to bedriven by portfolio of recently launched products Division had 7 blockbusters in portfolio in 2011 and expects to achieve 14 or more blockbusters by 2017 Industry-leading Pharmaceuticals pipeline with 73 … Read the full press release →

Holzkirchen, Germany, 3-11-2012 — /europawire.eu/ — Sandoz, the global leader in biosimilars, has started patient enrolment in a late stage clinical trial in the United States for its biosimilar epoetin alfa. The Phase III study will compare safety and efficacy of … Read the full press release →

Investment supports growing pipeline of biologics portfolio representing 25% of current clinical pharmaceutical research pipeline Singapore will operate as a technological competence center for biotechnology and pharmaceutical production Construction of new production facility to start in early 2013 and expected … Read the full press release →

As precaution, Italian ministry of health temporarily halts distribution of two seasonal influenza vaccines Agrippal and Fluad, produced at Novartis site in Italy Recent clinical trials of these influenza vaccines and administration during seasonal vaccination campaigns have shown no unexpected … Read the full press release →